Use of botulinum toxin A for drug-refractory trigeminal neuralgia: Preliminary report

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 111, Issue 1, 2011, Pages 47-50

  Bohluli, Behnam ^a   Motamedi, Mohammad Hosein Kalantar ^b   Bagheri, Shahrokh C ^c,d   Bayat, Mohammad ^e   Lassemi, Eshagh ^a   Navi, Fina ^a   Moharamnejad, Nima ^f  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c NORTHSIDE HOSPITAL   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; MUSCLE RELAXANT AGENT;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; CHRONIC DISEASE; CLINICAL TRIAL; FEMALE; HUMAN; MALE; MIDDLE AGED; NONPARAMETRIC TEST; PAIN ASSESSMENT; TREATMENT OUTCOME; TRIGEMINUS NEURALGIA;

ADULT; AGED; ANALYSIS OF VARIANCE; BOTULINUM TOXINS, TYPE A; CHRONIC DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROMUSCULAR AGENTS; PAIN MEASUREMENT; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; TRIGEMINAL NEURALGIA;

EID: 78650418411     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2010.04.043     Document Type: Article

References (12)

1. S. Katusic, D.B. Williams, C.M. Beard, E.J. Bergstralh, and L.T. Kurland Epidemiology and clinical features of idiopathic trigeminal neuralgia and glossopharyngeal neuralgia: similarities and differences, Rochester, Minnesota, 1945-1984 Neuroepidemiology 10 1991 276 281
2. M. Tatli, O. Satici, Y. Kanpolat, and M. Sindou Various surgical modalities for trigeminal neuralgia: literature study of respective long-term outcomes Acta Neurochir (Wien) 150 2008 243 255
3. S.R. de Siqueira, J.C. da Nbrega, J.T. de Siqueira, and M.J. Teixeira Frequency of postoperative complications after balloon compression for idiopathic trigeminal neuralgia: prospective study Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102 2006 e39 e45
4. D.W. Dodick, A. Mauskop, A.H. Elkind, R. DeGryse, M.F. Brin, and S.D. Silberstein Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study Headache 45 2005 315 324
5. Headache Classification Subcommittee of the International Headache Society The international classification of headache disorders: second edition Cephalalgia 24 Suppl 1 2004 9 160
6. M.H.K. Motamedi, H. Rahmat, E. Bahrami, A. Sadidi, F. Navi, M. Asadollahi, and P.S. Eshkevari Trigeminal neuralgia and radiofrequency J Calif Dent Assoc 37 2009 109 114
7. S.H. Lee, E.I. Levy, A.M. Scarrow, A. Kassam, and P.J. Jannetta Recurrent trigeminal neuralgia attributable to veins after microvascular decompression Neurosurgery 46 2000 356 361 discussion 361-2
8. D.K. Kim, C.A. Thomas, C. Smith, and M.B. Chancellor The case for bladder botulinum toxin application Urol Clin North Am 33 2006 503 510
9. N. Allam, J.P. Brasil-Neto, G. Brown, and C. Tomaz Injections of botulinum toxin type a produce pain alleviation in intractable trigeminal neuralgia Clin J Pain 21 2005 182 184
10. M. Porta, and M. Camerlingo Headache and botulinum toxin J Headache Pain 6 2005 325 327
11. U. Trk, S. Ilhan, R. Alp, and H. Sur Botulinum toxin and intractable trigeminal neuralgia Clin Neuropharmacol 28 2005 161 162
12. C. Ziga, S. Daz, F. Piedimonte, and F. Micheli Beneficial effects of botulinum toxin type A in trigeminal neuralgia Arq Neuropsiquiatr 66 3A 2008 500 503